FDA Approves Product Under Voucher for Rare Pediatric Disease Priority Review Voucher

Summary

The FDA has approved a product redeeming a priority review voucher for DESCOVY, a rare pediatric disease treatment, following the issuance of a notice as required by law. DESCOVY was initially approved on October 3, 2019.